Amylyx (AMLX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.39
- EPS estimate
- −$0.36
- EPS surprise
- −8.06%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 6, 2026
Amylyx reported Q2 2026 results on August 6, 2026. It posted a loss of $0.39 per share, wider than the estimated loss of $0.36, an 8.06% miss. The source shows no revenue for the quarter and no revenue estimate. The loss was narrower than the $0.46 per share lost in Q2 2025. Q1 2026 had also missed, by 9.50%.
The table covers 19 quarters, and 15 of them were losses. The exception was 2023, when all four quarters were profitable and annual EPS reached $0.70 on $380.7 million of revenue. From Q1 2024, losses returned, with $1.75 per share lost that quarter, and revenue has been blank in the table for most quarters since. The annual loss was $4.44 per share in 2024 and narrowed to $1.55 in 2025. Amylyx beat the EPS estimate in 8 of the 19 quarters. The Q1 2024 estimate shows as roughly zero, so that quarter's surprise figure is not meaningful.
Amylyx reported Q3 between November 6 and November 10 in each of the past four years. That points to early November 2026 for the next report. It will show whether the loss per share keeps narrowing year over year.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | −$0.36 | −$0.39 | −8.06% | $0.00 | SEC |
| Q1 2026 | May 7, 2026 | −$0.34 | −$0.37 | −9.50% | $0.00 | SEC |
| Q4 2025 | Mar 3, 2026 | −$0.35 | −$0.30 | +13.97% | $0.00 | SEC |
| Q3 2025 | Nov 6, 2025 | −$0.44 | −$0.37 | +15.10% | $0.00 | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.44 | −$0.46 | −3.51% | $0.00 | SEC |
| Q1 2025 | May 8, 2025 | −$0.48 | −$0.42 | +11.58% | $0.00 | SEC |
| Q4 2024 | Mar 4, 2025 | −$0.52 | −$0.55 | −5.77% | −$665,000.00 | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.70 | −$1.07 | −51.99% | $416,000.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.73 | −$1.07 | −46.58% | −$1.0M | SEC |
| Q1 2024 | May 9, 2024 | −$0.00 | −$1.75 | −43650.00% | $88.6M | SEC |
| Q4 2023 | Feb 22, 2024 | $0.23 | $0.07 | −69.27% | $108.4M | SEC |
| Q3 2023 | Nov 9, 2023 | $0.44 | $0.30 | −31.43% | $102.7M | SEC |
| Q2 2023 | Aug 10, 2023 | $0.19 | $0.31 | +63.16% | $98.2M | SEC |
| Q1 2023 | May 11, 2023 | −$0.24 | $0.02 | +108.31% | $71.4M | SEC |
| Q4 2022 | Mar 13, 2023 | −$0.82 | −$0.65 | +20.69% | $21.9M | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.97 | −$0.92 | +5.31% | $345,000.00 | SEC |
| Q2 2022 | Aug 11, 2022 | −$0.87 | −$0.93 | −6.59% | $0.00 | SEC |
| Q1 2022 | May 12, 2022 | −$0.69 | −$0.93 | −35.43% | $0.00 | SEC |
| Q4 2021 | Mar 31, 2022 | −$6.94 | −$4.23 | +39.01% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Amylyx (AMLX) last report earnings?
Amylyx last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did AMLX beat earnings estimates?
No. Amylyx reported EPS of −$0.39 for Q2 2026 against a −$0.36 estimate — a 8.06% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.